Increased phosphate content of fibrinogen in vivo correlates with alteration in fibrinogen behaviour.
Fibrinogen was purified from five patients admitted for hip-replacement surgery the day before (day 0), the day after (day 2) and and one week after the operation (day 8). The behaviour of each patient's three fibrinogens was compared in thrombin gelation assays and plasmin degradation experiments to investigate whether the reported increase in protein-bound phosphate at day 2 and day 8 had any effect on the functional behaviour of fibrinogen as has been demonstrated in vitro. It was found that the thickness of the fibrin fibres produced by thrombin increased markedly at day 2 and declined thereafter. Susceptibility to plasmin appeared to decrease post-operatively by 50% and remained at that level on day 8 despite the phosphate content returning to normal. This has also been shown for fibrinogen phosphorylated in vitro. We conclude, after testing the fibrinogens with and without alkaline phosphatase pretreatment, that our data most resemble the published findings for in vitro phosphorylation of fibrinogen by casein kinase II.
Martin
S C
SC
Institute of Biochemistry, Glasgow Royal Infirmary, Scotland.
Ekman
P
P
Forsberg
P O
PO
Ersmark
H
H
D000210:Acute-Phase Reaction / Q000097:blood*; D000368:Aged; D000369:Aged, 80 and over; D047388:Casein Kinases; D005260:Female; D005340:Fibrinogen / Q000737:chemistry* / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005782:Gels; D006622:Hip Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000032:analysis*; D010766:Phosphorylation; D011184:Postoperative Period; D011494:Protein Kinases / Q000378:metabolism*; D013917:Thrombin / Q000378:metabolism
D005782:Gels; D010710:Phosphates; D005340:Fibrinogen; D011494:Protein Kinases; D047388:Casein Kinases; D013917:Thrombin; D005341:Fibrinolysin